Abbott Diagnostics Scarborough, Inc. has recalled approximately 5,383,584 ID NOW diagnostic test kits, including ID NOW COVID-19 2.0, ID NOW Influenza A/B 2, and ID NOW RSV. These kits are being recalled because certain lots show a higher rate of "invalid" test results than expected. While no injuries have been reported, an invalid result prevents healthcare providers from accurately diagnosing a patient's condition. These test kits were distributed nationwide to hospitals, clinics, and other point-of-care facilities through authorized distributors.
An invalid test result means the device cannot provide a clear positive or negative diagnosis for COVID-19, the flu, or RSV. This failure can lead to delays in patient treatment or the need for repeated testing procedures.
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets.
Influenza A And Influenza B Multiplex Nucleic Acid Assay; Real Time Nucleic Acid.
Respiratory virus panel nucleic acid assay system.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.